skip to Main Content
About Us          Contact Us          |          
A lupus awareness and educational program from the American College of Rheumatology

Hear from Clinical Researchers, Principal Investigators, Rheumatologists, Referring Physicians, Industry Leads, and Patient Advocates & Patients

The American College of Rheumatology (ACR) will host a Clinical Trial Summit: Engaging Diverse Participants in Lupus Clinical Trials: The Path Forward, virtually on Friday, July 21, 2023, from 11:00 am – 4:00 pm ET. The goal of this non-CME program is to connect rheumatology leaders, referring physicians, researchers, principal investigators, and industry leaders to discuss challenges and strategies in diversifying rheumatology clinical trials utilizing lupus as a case study.

Through case studies, panel & roundtable breakout discussions the summit delivers the real-world experiences and best practices needed to diversify rheumatology clinical trials, planning and management.

Event Agenda

Friday, July 21, 2023
11:00 am – 4:00 pm Eastern
 

Time
Name
Description
11:00 – 11:05 AM
ACR Welcome and Opening Remarks
Douglas White, MD, PhD
ACR President
Chair of Rheumatology, Head of the Rheumatology Research Lab
Gundersen Health System
11:05 – 11:10 AM
Greetings, COIN Committee
Rosalind Ramsey-Goldman, MD, DrPH
ACR, COIN Chair
Gallagher Research Professor of Rheumatology
Northwestern University Feinberg School of Medicine
11:10 – 12:00 PM
Panel A: Patient Perspective in Lupus Clinical Trials
Stacey Kennedy-Conner
FACE Specialist, Lupus
Representative, Member of Patient
Advocates for Lupus Studies at Lupus Therapeutics
Chicago Public Schools

Aleta McLean, LPC
Senior Director of Client Services and Outcomes Tracking
Open Hands Atlanta

Monique Gore Massy
National Lupus Advocate/Global
Patient Consultant #LemonadeMaker

Moderator(s):
Christele Felix
LupusChat
Chief Operating Officer

Charmayne Dunlop-Thomas, MS, MPH
Emory University School of Medicine
Associate Director Research Projects

12:00 – 12:30 PM
Keynote Address: Diversity and Clinical Trials
RDML Richardae Araojo, PharmD, MS
Associate Commissioner for Minority Health
Director of the Office of Minority Health and Health Equity
U.S. Food and Drug Administration

Moderator:
Sarfaraz A. Hasni, MD, MSc,
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Director Lupus Clinical Research

12:30 – 1:15 PM
Panel B: Promising Practices in Lupus Clinical Trial Diversity and Awareness
Saira Z. Sheikh, MD
Linda Coley Sewell Distinguished Professor of Medicine
University of North Carolina
School of Medicine

Pamela Payne-Foster, MD, MPH
Professor of Community Medicine and Population Health
University of Alabama - Tuscaloosa

Joy Buie, Ph.D., MSCR, RN
Director of Research
Lupus Foundation of America

Moderator:
Allen Anandarajah, MD, MBBS
University of Rochester Medical Center
Professor of Medicine

1:15 – 1:30 PM
Break
ACR Informational Slides
1:30 – 2:15 PM
Panel C: The Role of the Pharmaceutical Industry in Diversification of Clinical Trials
Sergio Arce, MD, PhD
Medical Director, Global Clinical Development, Autoimmune Diseases
RemeGen Biosciences, Inc.

Coby Hobar, MD
Clinical Development Lead
Bristol-Myers Squibb

Jodi Bridge
Senior Clinical Operations Lead Gazyva in Rheumatology/Nephrology
Hoffmann-LaRoche Limited

Moderator:
Kenneth Kalunian, MD
UC San Diego Health
Professor of Clinical, Medicine

2:15 – 2:20 PM
Breakout Session Transition
Rosalind Ramsey-Goldman, MD, DrPH
ACR, COIN Chair
Gallagher Research Professor of Rheumatology
Northwestern University Feinberg School of Medicine
2:20 – 3:20 PM
Breakout Session: Roundtable Discussions
 
 
Engaging communities and building genuine long term relationships
Candace Feldman, MD, MPH, ScD
Assistant Professor of Medicine
Harvard Medical School
Brigham, and Women's Hospital
 
Breakout session 2: Creating a network of trial sites in underserved communities
Ashira D. Blazer, MD, MSCI
Assistant Attending Physician and Assistant Professor of Medicine
Weil Cornell Medical College
Hospital for Special Surgery
 
Session 3: Developing a diverse pool of investigators and staff
Irene Blanco, MD, MS
Professor of Medicine
Northwestern University
Feinberg School of Medicine
 
Session 4: Providing sustainable support and standardized platform
Donald Thomas, MD, FACP, FACR, RhMSUS
Clinical Associate Professor of Medicine; Uniformed Services
University of the Health Sciences
Arthritis and Pain Associates of P.G. County
3:20 – 3:50 PM
Breakout Session Report Out
Speaker(s):

Breakout Session # 1
Candace Feldman, MD, MPH, ScD

Breakout Session # 2
Ashira D. Blazer, MD, MSCI

Breakout Session # 3
Irene Blanco, MD, MS

Breakout Session # 4
Donald Thomas, MD, FACP,
FACR, RhMSUS™

Moderator(s):
Allen Anandarajah, MD, MBBS
University of Rochester Medical Center
Professor of Medicine

Sarfaraz A. Hasni, MD, MSc,
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Director Lupus Clinical Research

3:50 – 4:00 PM
Closing Remarks
Rosalind Ramsey-Goldman, MD, DrPH
ACR, COIN Chair
Gallagher Research Professor of Rheumatology
Northwestern University
Feinberg School of Medicine

Questions? Contact us at coin@rheumatology.org

Thank You, Clinical Trial Summit Planning Committee!

Allen Anandarajah, MD, MBBS, University of Rochester Medical Center

Irene Blanco, MD, MS, Northwestern University

Charmayne Dunlop-Thomas, MS, MPH, Emory University School of Medicine

Candace H. Feldman, MD, MPH, Harvard Medical School, Brigham, and Women’s Hospital

Rosalind Ramsey-Goldman, MD, DrPH, Northwestern University

Sarfaraz A. Hasni, MD, MSc, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Saira Z. Sheikh, MD, University of North Carolina School of Medicine

American College of Rheumatology logo

Back To Top